ObsEva (NASDAQ:OBSV) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the stock.

ObsEva Stock Down 15.5 %

Shares of NASDAQ:OBSV opened at $0.10 on Friday. The stock has a market cap of $7.94 million, a price-to-earnings ratio of -0.01 and a beta of 0.68. ObsEva has a 12-month low of $0.08 and a 12-month high of $2.14. The business’s 50 day moving average is $0.02 and its 200 day moving average is $0.04.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.